Paolo Lopedote

7PUBLICATIONS
21CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2026
Allogeneic heamatopoietic stem cell transplant in patients with refractory T-cell large granular lymphocytic leukaemia: A single-centre experience.

|Oct 31, 2025
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.

Paolo Lopedote, Geoffrey Shouse, Lu Chen

|Apr 03, 2025
A chemotherapy-free regimen of acalabrutinib, umbralisib and ublituximab achieved high response rates and undetectable minimal residual disease in patients with untreated mantle cell lymphoma.

Paolo Lopedote, Geoffrey Shouse, Sandrine Puverel

|Apr 23, 2024
Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis.

Paolo Lopedote, Benjamin Evans, Alfredo Marchetti

|Jun 22, 2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond.

Salvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis

|Mar 21, 2023
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab.

Paolo Lopedote, Mazyar Shadman

Pageof 2

Frequent Collaborators

2 joint publications

Salvatore Perrone

1 joint publications

Mario Levis

1 joint publications

Alice Di Rocco

1 joint publications

Stephen Douglas Smith